InVivoMAb Anti-HRSV F/Fusion glycoprotein F0 Antibody (RSV19)

Description: InVivoMAb Anti-HRSV F/Fusion glycoprotein F0 Antibody (RSV19) [RSV19] (RA12085) is a human monoclonal antibody detecting Fusion glycoprotein F0 in Blocking, ELISA.
Host species: Human
Isotype: IgG1, kappa
Species reactivity: Human respiratory syncytial virus A (strain A2),Human respiratory syncytial virus B (strain B1)
Form: Liquid
Storage buffer: 0.01M PBS, pH 7.4.
Concentration: 1 mg/ml
Purity: >95% as determined by SDS-PAGE.
Clonality: Monoclonal
Applications: Blocking, ELISA
Target: Fusion glycoprotein F0, Fusion glycoprotein F2, F2, p27, Intervening segment, Pep27, Peptide 27, Fusion glycoprotein F1, F1, F
Purification: Protein A/G purified from cell culture supernatant.
Endotoxin level: Please contact with the lab for this information.
Stability and Storage: Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.
Alternative Names:
Background: Fusion glycoprotein F0 is a ~63 kDa protein. Inactive precursor that is cleaved at two sites by a furin-like protease to give rise to the mature F1 and F2 fusion glycoproteins.
Note: For research use only. Not suitable for clinical or therapeutic use.